Replies to post #371650 on Anavex Life Sciences Corp (AVXL)

[Pazzo1212]

What would be awesome if that CTAD has sessions led by scientists who peer reviewed the last two articles highlighting the MOA of the SIGMAR1 receptor, then Missling speaks about the great AD trial results.

It would ultimately set up the paradigm shift in the CNS world, and catapult Anavex to becoming the most exciting drug in the world!